A complementary combination of delivery device and drug formulation for inhalation therapy in preschool children

Karen G Schüepp1, Sunalene Devadson, Christina Roller

  • 1Swiss Paediatric Respiratory Research Group, Division of Respirtatory Medicine, University Children's Hospital, Zurich, Switzerland.

Swiss Medical Weekly
|April 24, 2004
PubMed

Insights

A new perforated vibrating membrane nebuliser significantly improved lung drug delivery in preschool children. This optimized device delivered 36-38% budesonide to the lungs, a substantial increase from conventional nebulisers (max 8%).

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Drug Delivery
  • Pharmacokinetics

Background:

  • Inhalation therapy in preschool children often suffers from low lung drug deposition.
  • Conventional nebulisers show limited efficiency in delivering medication to the lungs of young children.

Purpose of the Study:

  • To evaluate the lung delivery efficiency of an optimized combination of a perforated vibrating membrane nebuliser and budesonide formulation in preschool children.
  • To compare this novel system with a conventional nebuliser for budesonide delivery.

Main Methods:

  • A comparative study involving six three-year-old children.
  • Radiolabelled budesonide solutions were administered using a conventional nebuliser (MMD 4.2 mm) and a perforated vibrating membrane nebuliser (MMD 2.5 mm).
  • Lung deposition was quantified for both devices.

Main Results:

  • The perforated vibrating membrane nebuliser achieved significantly higher lung deposition of budesonide (36% and 38%).
  • Conventional nebulisers demonstrated markedly lower lung deposition, with a maximum of 8%.

Conclusions:

  • Optimized combinations of delivery devices and drug formulations can substantially improve inhaled therapy efficacy in preschool children.
  • Perforated vibrating membrane nebulisers represent a promising advancement for efficient inhalation therapy in this pediatric population.

Related Concept Videos

Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Drug Delivery: Miscellaneous Routes01:22

Drug Delivery: Miscellaneous Routes

Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection,  and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Additional Routes of Drug Administration01:18

Additional Routes of Drug Administration

Choosing the appropriate route of drug administration is significantly influenced by two key factors: the therapeutic objectives and the inherent properties of the drug being used.
Administering drugs via inhalation allows for the direct delivery of gaseous, volatile substances or droplets to different parts of the respiratory tract. One of the advantages of the inhalation route is the rapid absorption of drugs into the circulatory system, which is possible because of the large surface area of...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices01:28

Parenteral Drug Delivery Systems: Injectables, Implants, and Infusion Devices

Parenteral drug delivery systems play a crucial role in modern therapeutics by enabling the direct administration of drugs into the systemic circulation, bypassing the gastrointestinal tract. These systems are particularly valuable for poorly absorbed oral medications that are unstable in the digestive environment or require rapid onset or sustained therapeutic levels. Delivery is achieved through intravenous, intramuscular, or subcutaneous routes, each selected based on the drug's properties...